Plebanski M - Search Results

1

A Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes.

Xiang SD, Gao Q, Wilson KL, Heyerick A, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Vaccines (Basel). 2015 Oct 29;3(4):875-93. doi: 10.3390/vaccines3040875. Vaccines (Basel). 2015. PMID: 26529027 Free PMC article.

2

Vaccines that facilitate antigen entry into dendritic cells.

Gamvrellis A, Leong D, Hanley JC, Xiang SD, Mottram P, Plebanski M. Gamvrellis A, et al. Among authors: plebanski m. Immunol Cell Biol. 2004 Oct;82(5):506-16. doi: 10.1111/j.0818-9641.2004.01271.x. Immunol Cell Biol. 2004. PMID: 15479436 Review.

3

Pathogen recognition and development of particulate vaccines: does size matter?

Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Methods. 2006 Sep;40(1):1-9. doi: 10.1016/j.ymeth.2006.05.016. Methods. 2006. PMID: 16997708 Review.

4

Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity.

Kalkanidis M, Pietersz GA, Xiang SD, Mottram PL, Crimeen-Irwin B, Ardipradja K, Plebanski M. Kalkanidis M, et al. Among authors: plebanski m. Methods. 2006 Sep;40(1):20-9. doi: 10.1016/j.ymeth.2006.05.018. Methods. 2006. PMID: 16997710

5

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.

Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, Ghildyal R, Vardaxis N, Plebanski M. Mottram PL, et al. Among authors: plebanski m. Mol Pharm. 2007 Jan-Feb;4(1):73-84. doi: 10.1021/mp060096p. Mol Pharm. 2007. PMID: 17274665

6

Investigation of a novel approach to scoring Giemsa-stained malaria-infected thin blood films.

Proudfoot O, Drew N, Scholzen A, Xiang S, Plebanski M. Proudfoot O, et al. Among authors: plebanski m. Malar J. 2008 Apr 21;7:62. doi: 10.1186/1475-2875-7-62. Malar J. 2008. PMID: 18426594 Free PMC article.

7

Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.

Greenwood DL, Dynon K, Kalkanidis M, Xiang S, Plebanski M, Scheerlinck JP. Greenwood DL, et al. Among authors: plebanski m. Vaccine. 2008 May 23;26(22):2706-13. doi: 10.1016/j.vaccine.2008.03.025. Epub 2008 Apr 3. Vaccine. 2008. PMID: 18448209

8

Promising particle-based vaccines in cancer therapy.

Xiang SD, Scalzo-Inguanti K, Minigo G, Park A, Hardy CL, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Expert Rev Vaccines. 2008 Sep;7(7):1103-19. doi: 10.1586/14760584.7.7.1103. Expert Rev Vaccines. 2008. PMID: 18767957 Free article. Review.

9

Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.

Xiang SD, Selomulya C, Ho J, Apostolopoulos V, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May-Jun;2(3):205-18. doi: 10.1002/wnan.88. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010. PMID: 20391461 Review.

10

Methods to measure T-cell responses.

Plebanski M, Katsara M, Sheng KC, Xiang SD, Apostolopoulos V. Plebanski M, et al. Expert Rev Vaccines. 2010 Jun;9(6):595-600. doi: 10.1586/erv.10.53. Expert Rev Vaccines. 2010. PMID: 20518715 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters